Background: Sustained vascular smooth muscle contraction is mediated by extracellular Ca 2؉ influx through L-type voltage-gated Ca 2؉ channels (VGCC) and RhoA/Rho-associated kinase (ROCK)-dependent Ca 2؉ sensitization of the contractile machinery. VGCC activation can also trigger an ion-independent metabotropic pathway that involves G-protein/phospholipase C activation, inositol 1,4,5-trisphosphate synthesis, and Ca 2؉ release from the sarcoplasmic reticulum (calcium channel-induced Ca 2؉ release). We have studied the functional role of calcium channel-induced Ca 2؉ release and the inter-relations between Ca 2؉ channel and RhoA/ROCK activation.
lipase C (PLC) activation and inositol 1,4,5-trisphosphate (InsP 3 ) synthesis. [11] [12] [13] [14] Although other membrane proteins in the receptor/G-protein/PLC cascade have been proposed to be voltage-sensitive, [15] [16] [17] it has been shown that L-type Ca 2ϩ channels are necessary for depolarization-induced Ca 2ϩ release in vascular 14,18 -20 and skeletal 21 muscle. Therefore, plasmalemmal Ca 2ϩ channels in VSM have been suggested to act as voltage sensors that mediate ion-independent coupling between membrane depolarization and SR Ca 2ϩ release (Ca 2ϩ channel-induced Ca 2ϩ release [CCICR] ). 14, 20 The precise physiological role of CCICR and its inter-relations with the RhoA/ROCK pathway are as yet unexplored. Herein, we show that, unexpectedly, CCICR is necessary for sustained VSM contraction and that maintenance of arterial tone requires Ca 2ϩ channel-dependent RhoA activation. Our data suggest that sarcolemmal VGCC not only mediate the Ca 2ϩ influx that triggers contraction but also metabotropically regulate SR Ca 2ϩ release and RhoA activation to sensitize the contractile machinery. These novel findings suggest that Ca 2ϩ channels have a role in the regulation of VSM tonus much broader than previously thought and provide a comprehensive view of myocyte contractility. This work helps identify mechanisms responsible for hypertension as well as arterial (eg, coronary or cerebral) vasospasms.
Subjects and Methods

Animal Models
Rats and mice were anesthetized with ketamine (80 mg/kg intramuscular). Rabbits were anesthetized with sodium pentobarbital (75 mg/kg intravenous). Cav1.2 knockout animals were generated at the Institut für Pharmakologie und Toxikologie, München, Germany. 22, 20 All of the experimental procedures were approved by the Institutional Animal Care and Use Committee and were conducted in conformity with institutional guidelines. Cytosolic [Ca 2ϩ ] and patch clamp recordings from dispersed myocytes were performed as previously described. 14 
Cytosolic Ca 2؉ Measurements and Electrophysiological Recordings in Isolated Myocytes
Confocal Microscopy and Immunocytochemistry
Immunocytochemical studies were performed on fixed cells following standard protocols. For details, see Methods in the online Data Supplements.
Measurement of Contractility in Arterial Rings and RhoA Activation Assay
Contractility of arterial rings was studied as previously described. 18 RhoA activity was determined from quickly frozen arterial rings (immersed in liquid nitrogen) using the colorimetric G-LISA RhoA activation assay biochemistry kit (Cytoskeleton, Denver, CO). For details, see Methods in the online Data Supplements.
Simultaneous Measurements of Fluorescence and Contractility
Basilar arteries (12-14 mm) were incubated in Hank's containing Fura 2 AM 1.4 mol/L for 1 hour at room temperature. Experiments were performed as previously described. 19 
Reversible Permeabilization
Reversible permeabilization was achieved by a modification of previous methods. 23, 24 For details and solutions, see Methods in the Online Data Supplement at http://circres.ahajournals.org.
Statistical Analysis
Data are expressed as meanϮstandard error and the statistical significance was estimated using the Student t test. Values of PϽ0.05 were considered significant.
Results
Sustained Depolarization-Evoked Vascular Myocyte Contraction Requires Metabotropic Ca 2؉ Release From the SR
To investigate the functional role of metabotropic Ca 2ϩ release from the SR evoked by VGCC activation (CCICR), 14, 20, 25 basilar arterial rings were stimulated by exposure to an external solution containing 70 mmol/L K ϩ , which depolarizes isolated currentclamped arterial myocytes. 14 The high K ϩ solution shifted the membrane potential of basilar VSM cells from Ϫ50 mV to ϷϪ20 mV. Depolarization with 70K triggered an isometric contraction that showed an initial fast and transient (phasic) component, followed by a slowly increasing (tonic) component, which was generally maintained until the end of the stimulus ( Figure 1A ; Online Figure IA and B). These phasic and tonic components were also observed in contractions evoked by application of ATP, a vasoactive agent that induces activation of VGCC 26, 18 (Figure 1B ). Treatment of the arteries with cyclopiazonic acid (CPA), an SR Ca 2ϩ ATPase inhibitor that depletes Ca 2ϩ stores without effects on VGCC (online Figure IIA and B) , selectively reduced the tonic component of contractions evoked by either high K ϩ or ATP ( Figure 1A and 1B). Similar results (decrease of the sustained phase of arterial contraction) were observed with two other drugs (thapsigargin and ryanodine) that also reduce Ca 2ϩ storage in SR (Online Figure IIC and IID). These data indicated that the sustained component of depolarization-evoked VSM contraction depends on Ca 2ϩ release from intracellular stores, possibly as a consequence of CCICR. CCICR is inhibited by organic VGCC antagonists; 14, 18 hence, we tested the effect of nifedipine on depolarizationevoked contractions. Nifedipine was more potent to inhibit the tonic than the phasic components of contractions. Nifedipine (10 nmol/L) produced a marked reduction of the high K-evoked or ATP-evoked tonic contraction leaving intact the phasic period. At higher concentrations of nifedipine (100 nmol/L), the two phases of contraction were abolished ( Figure 1C and 1D; Online Figure IIE and IIF). These results suggest that VSM cell contraction elicited by cell depolarization depends on both ionotropic (Ca 2ϩ entry) and metabotropic (CCICR) actions of plasmalemmal Ca 2ϩ channels.
To test whether depolarization-evoked sustained VSM contraction does involve metabotropically induced Ca 2ϩ release, arterial rings were exposed to U73122, an inhibitor of PLC. 14 This treatment left unaffected the phasic component of the 70K-evoked contraction but markedly reduced the tonic component. U73343, a structurally closely related compound that does not inhibit PLC, did not significantly affect VSM contrac-tility ( Figure 2A ). Similar results were obtained in basilar arterial rings contracted with ATP and treated with U73122 ( Figure 2B ). Further support for the notion that the G-protein/PLC pathway participates in depolarization-induced tonic contractions came from experiments on intact arteries in which myocytes had been reversibly permeabilized in the presence of GDP␤S to inhibit G-protein activation. 14, 23, 24 In these arteries, the tonic component of the 70K-evoked VSM contraction was also selectively reduced, whereas the phasic component of contraction and the mechanical signal induced by caffeine (a drug that directly elicits Ca 2ϩ release from the SR) were unaltered ( Figure 2C and 2D). Together, these results further supported the notion that stimulation of the G-protein/PLC cascade subsequent to membrane depolarization and Ca 2ϩ channel activation leads to the SR Ca 2ϩ release necessary for maintained VSM contraction.
Non-standard Abbreviations and Acronyms
Sustained Depolarization-Evoked Contraction Requires G-Protein-Dependent and InsP 3 -Dependent RhoA/ROCK Activation
In VSM, a Ca 2ϩ sensitization mechanism mediated by the RhoA/ROCK pathway seems to participate in the depolarizationevoked contraction; however, the underlying mechanisms are not well-known. 6 -10 We tested in immunostained isolated myocytes the redistribution of activated RhoA and its displacement toward the plasma membrane in response to high K ϩ -induced depolarization ( Figure 3A through 3C). 9, 27 Because ROCK is a RhoA downstream effector, we studied in intact pressurized arteries the effect of Y27632, a ROCK inhibitor, 1 on the cytosolic Ca 2ϩ and mechanical responses to high K ϩ . ROCK blockade did not modify the Ca 2ϩ signal elicited by depolarization but selectively inhibited the tonic component of the contraction ( Figure 3D ). Qualitatively similar results (inhibition of the tonic phase of contraction) were obtained in arterial rings treated with HA1077, another ROCK inhibitor structurally unrelated to Y27632 1 (Online Figure IIIE and IIIF). These experimental observations further suggested that the depolarization-evoked sustained phase of contraction requires, at least in part, RhoA/ROCK activation.
To show the parallel metabotropic regulation of tonic contraction and RhoA activation, we performed experiments in reversibly permeabilized arteries ( Figure 2C and 2D) that were frozen at the end of the depolarization pulse (Ϸ10 minutes after exposure to high K ϩ ) to directly measure RhoA activity. Application of GDP␤S and heparin (inhibitors of G-protein activation and InsP 3 receptors, respectively) selectively reduced the tonic component of the 70K-evoked contractions and also decreased RhoA activity induced by depolarization ( Figure 4 ; Online Figure IC) . These observations supported the view that metabotropic Ca 2ϩ release from the SR elicited by membrane depolarization maintains tonic contractions through activation of the RhoA/ROCK pathway. 
Essential Role of L-type Ca 2؉ Channel Activation and Ca 2؉ Channel-Induced Ca 2؉ Release in Depolarization-Evoked RhoA Activation and Sustained Myocyte Contraction
Because depolarization-evoked tonic myocyte contraction is paralleled by metabotropic RhoA/ROCK activation, we tested to see whether blockade of tonic contractility with nifedipine ( Figure 1C and 1D) also altered RhoA activity. As expected, 70K-induced contractions and RhoA activation in arterial rings were fully prevented by nifedipine ( Figure 5A , top and bottom), thus suggesting that Ca 2ϩ channel activation is required to increase RhoA activity. The critical role of VGCC activation (independently of membrane depolarization) in RhoA regulation was further supported by two sets of experiments. First, the application of FPL64176 (FPL), a selective L-type Ca 2ϩ channel agonist with minor effects on the resting membrane potential, 14, 18 induced a contraction that was fully blocked by nifedipine ( Figure 5B and 5C, top panels; Online Figure ID and IE). RhoA activity, which increased by FPL in parallel with the mechanical response, was also almost abolished by nifedipine application ( Figure  5B and 5C, bottom panels). Second, in a conditional Cav1.2 (L-type) Ca 2ϩ channel knockout mice model, 22, 20 contractile responses to 70K and FPL were greatly reduced in parallel with inhibition of RhoA activity ( Figure 6 ). In these genetically modified animals, contractions induced by application of either phenylephrine or caffeine (because of Ca 2ϩ release from InsP 3 or ryanodine-sensitive stores, respectively) 28, 29 were unaffected, thus indicating that VGCC deficiency did not alter other physiological features of the VSM cells. The RhoA/ROCK pathway was maintained functional in Cav1.2 null myocytes because it was activated by phenylephrine with similar potency as in control cells ( Figure 6D ). Moreover, the sustained contraction evoked by phenylephrine was blocked by pharmacological ROCK inhibition (Online Figure IV) . To distinguish between the effects of Ca 2ϩ channel activation (and the downstream metabotropic pathway) and Ca 2ϩ entry/release on RhoA activation, we performed experiments in arteries bathed in Ca-free solutions (0Ca plus 1 mmol/L EGTA; estimated [Ca 2ϩ ] I Ͻ100 nmol/L) to prevent any transmembrane Ca 2ϩ influx. In these conditions, caffeine induced a transient Ca 2ϩ release signal that triggered arterial contraction (Online Figure VA) . These effects of caffeine decreased progressively as the SR stores were depleted of Ca 2ϩ ( Figure 7A ). RhoA activity measured 10 minutes after caffeine application was similar to control values ( Figure 7B and 7C), thus indicating that caffeine-induced Ca 2ϩ release and contraction occur without involvement of the RhoA/ ROCK pathway. Pharmacological inhibition of ROCK did not produce any effect on the mechanical responses to caffeine (Online Figure VB) . Application of a membranepermeant InsP 3 derivative also failed to induce contraction and RhoA activation in arterial rings (Online Figure VI) . Therefore, SR Ca 2ϩ release per se (bypassing Ca 2ϩ channelinduced metabotropic activation) does not seem to be sufficient to activate RhoA. In contrast to caffeine, FPL (that also induced a transient Ca 2ϩ signal and arterial contraction; online Figure VC ) elicited a marked RhoA activation that decreased with time as the SR was depleted of Ca 2ϩ ( Figure  7D ). On exposure to FPL, RhoA activity increased to a maximal value that started to decrease 10 minutes after treatment ( Figure 7E and 7F) . These findings contrast with the results shown before in the presence of extracellular Ca 2ϩ , a condition in which FPL induced sustained contraction and RhoA activation ( Figure 5B ). In accord with these observations, FPL-induced contraction was inhibited by pharmacological blockade of ROCK (Online Figure VD) .
It is known that phosphorylation of myosin light chain in KCl-stimulated myocytes is highly sensitive to [Ca 2ϩ ] i ; 8 hence, we sought to determine whether changes in extracellular [Ca 2ϩ ] can modify RhoA activation. Experiments were performed to compare the data described before in arteries bathed in 0Ca plus EGTA solutions (estimated [Ca 2ϩ ] Ͻ100 nmol/L) with preparations exposed to 0Ca solutions without EGTA added (estimated [Ca 2ϩ ] Ϸ7 mol/L) for more than 60 minutes. In this last solution, both caffeine-evoked contraction and FPL-induced RhoA activation remained similar to the values observed in control conditions, before application of any stimulus ( Figures 8A, 8B , 7A, and 7D). FPL elicited a sustained contraction paralleled by an increase in RhoA activity that, after reaching a maximal value, remained almost constant or declined slowly during treatment ( Figures  8C, 8D , 7E, and 7F). FPL-induced sustained contraction was decreased by pharmacological ROCK inhibition, whereas the cytosolic Ca 2ϩ signal was not affected (Online Figure VE) . Interestingly, the level of FPL-evoked RhoA activation, after 10 minutes of treatment, was not significantly different in arterial rings bathed in either Ϸ7 mol/L (136%Ϯ8%; nϭ8; Figure 8D ) or 2.5 mmol/L (143%Ϯ6%; nϭ10; Figure 5B ) Ca 2ϩ (Pϭ0.18), thus suggesting that VSM cells have a highly effective Ca 2ϩ uptake system that can maintain refilling the intracellular stores even when extracellular [Ca 2ϩ ] is reduced to mol/L levels.
Altogether, these data suggest that depolarization-evoked sustained RhoA activation and myocyte contraction do not depend on the change in the membrane potential per se or the simple release of Ca 2ϩ from the SR, but they require the simultaneous activation of VGCC and the downstream stimulation of a metabotropic pathway leading to InsP 3 synthesis and Ca 2ϩ release. Therefore, CCICR has a major role in tonic VSM contractility because it links Ca 2ϩ channel activation with metabotropic Ca 2ϩ release and sensitization (RhoA/ ROCK stimulation).
Discussion
In this article, we describe that besides their classical ionotropic role responsible for Ca 2ϩ entry and the Ca 2ϩ /calmodulindependent activation of myosin light chain kinase, L-type Ca 2ϩ channels have other unexpected functions required for maintenance of depolarization-evoked contraction in VSM cells. We show that L-type Ca 2ϩ channel activation constitutes the key 
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event that triggers depolarization-dependent metabotropic Ca 2ϩ release from SR and smooth muscle sensitization through activation of the RhoA/ROCK pathway. It had been described before that in the absence of extracellular Ca 2ϩ influx, Ca 2ϩ channels of VSM cells act as voltage sensors that couple membrane depolarization to InsP 3 synthesis and Ca 2ϩ release from SR (CCICR). 14, 25, 20 We now show that in normal conditions, CCICR mediates Ca 2ϩ release and sensitization of the contractile apparatus necessary to generate sustained VSM contractions.
Maintenance of Depolarization-Evoked Vascular Myocyte Contraction Requires Functional Ca 2؉ Channels and Metabotropic Ca 2؉ Release From the SR
In agreement with previous studies on other arteries, 7,9 high K ϩ -evoked contraction in basilar arterial rings exhibited a time course characterized by an early transient phase followed by a tonic sustained component. Transient and sustained phases in vascular myocyte contraction were also observed after application of agonists that activate membrane VGCC. 18 In this article, we provide strong evidence indicating that, besides transmembrane Ca 2ϩ influx, the sustained phase of contraction also depends on Ca 2ϩ release from internal stores. Therefore, CCICR, a mechanism described in arteries bathed without external Ca 2ϩ , 14 seems to have a major functional role in arterial contraction under normal conditions. Exposure to high KCl is often used as a tool to bypass G-protein-coupled receptor stimulation and activate smooth muscle by changing the K ϩ equilibrium potential and clamping membrane potential above resting level. 10 However, it is well-established that in several cell types (including VSM cells) membrane depolarization can induce direct activation of the G-protein-PLC cascade, leading to InsP 3 synthesis and Ca 2ϩ release. In vascular 14, 25, 20 as well as in skeletal muscle cells, 21 a great deal of experimental evidence exists supporting the view that VGCC are the voltage sensors linking membrane depolarization to G-protein activation, InsP 3 synthesis, and Ca 2ϩ release. In bronchial smooth muscle 17 and megakaryocytes lacking VGCC, 16 other membrane proteins have been proposed to also have intrinsic voltage sensitivity. 16 In the present set of experiments, the role of CCICR on VSM contraction, studied before in isolated myocytes, has been investigated in arterial rings and reversibly "permeabilized" arteries. 23, 24 These last preparations better-represent the in vivo physiological conditions yet permit pharmacological modifications of the extracellular and intracellular media. The data show that sustained depolarization-evoked vascular contraction depends on G-protein/PLC/InsP 3 -mediated Ca 2ϩ release from the SR, a metabotropic pathway triggered by VGCC activation. We find particularly conclusive the experiments performed using the conditional L-type Ca 2ϩ channel knockout mouse, in which we have recently shown the strict dependence of depolarization-evoked Ca 2ϩ release on the maintenance of functional Ca 2ϩ channels. 20 In this animal model, protracted VSM contraction induced by either membrane depolarization (exposure to high K ϩ ) or pharmacological Ca 2ϩ channel activation (application of FPL) was reduced in parallel with the decrease of channel expression. However, contractions induced by either caffeine, which directly activates Ca 2ϩ release from stores, 29, 30 or phenylephrine, which activates the G-protein/PLC cascade and ROCK, 28 were unaltered. Therefore, it seems that VGCC have two different roles in the contractile response to depolarization. At first instance, membrane depolarization causes massive Ca 2ϩ entry, myosin light chain kinase activation, and a phasic contraction. 31 During maintained depolarization, channels undergo a conformational change (switching between inactive and open states) that triggers the metabotropic cascade, resulting in Ca 2ϩ release from SR and tonic contraction. Ca 2ϩ channel inactivation and the displacement of the membrane potential toward the Ca 2ϩ equilibrium potential drastically reduce transmembrane Ca 2ϩ influx. However, a small steady-state Ca 2ϩ channel activity and Ca 2ϩ current have been described in sustained depolarized myocytes. 32, 33 Therefore, it is possible that a residual transmembrane Ca 2ϩ influx, without effect on the contractile machinery itself, contributes to refilling of peripherally located SR, in which membranes of the plasmalemma and the superficial SR come close together. 34 Accumulation of Ca 2ϩ in the SR would then permit subsequent release of enough Ca 2ϩ to activate or sensitize the contractile apparatus. This proposal explains why both the phasic and tonic components of contraction depend on extracellular Ca 2ϩ . The higher sensitivity of the tonic phase of contraction to nifedipine could be explained because it is known that this drug has more affinity for the inactivated state of the Ca 2ϩ channels than for channels that are in the closed or open states. 35 Because before stimulation channels are mainly in the closed state, a higher dose of the antagonist is required to block the phasic component of the contraction.
Sustained Depolarization-Evoked Contraction Requires L-type Ca 2؉ Channel-Dependent Metabotropic RhoA/ROCK Activation
In accord with previous observations, 9, 27 we have shown in immunostained isolated myocytes the redistribution of activated RhoA and its displacement toward the plasma membrane after high K ϩ induced depolarization. In intact arteries, pharmacological inhibition of ROCK (a downstream effector of RhoA) selectively inhibited the tonic phase of contraction without altering the Ca 2ϩ signal. Therefore, the data suggested that besides metabotropic Ca 2ϩ release, activation of the RhoA/ROCK pathway is necessary for tonic myocyte contraction. In reversibly permeabilized arteries, RhoA activity was found increased in sustained depolarized arteries, and both contraction and RhoA activation decreased in parallel after G-protein blockade with GDP␤S or inhibition of InsP 3 receptors with heparin. Hence, high K ϩ -induced sustained contraction requires G-protein-mediated RhoA activation and Ca 2ϩ sensitization, a phenomenon that was previously thought to be restricted only to receptor-mediated forms of smooth muscle activation. 3 Because RhoA/Rho kinase is activated by G-proteincoupled receptor stimulation, 4,5 the apparent high K ϩinduced activation of RhoA/ROCK could, in fact, be attributable to activation of a G-protein-coupled receptor with intrinsic voltage sensitivity rather than to membrane depolarization. 36 This possibility was discarded because FPL, a Ca 2ϩ channel agonist that can activate Ca 2ϩ channels without affecting membrane potential, 14, 18 induced arterial contraction and RhoA activation in a qualitatively similar way to the changes in the same parameters evoked by KCl. Moreover, in conditional Cav1.2 knockout mice, the absence of FPLinduced or depolarization-induced L-type Ca 2ϩ channels activation was paralleled by the lack of RhoA activation and contraction. In this animal model, contraction induced by caffeine, which bypassed plasma membrane depolarization, was unchanged. Similarly, RhoA activation induced by phenylephrine, which is G-protein-mediated, was also unaltered. Therefore, these data strongly suggest that functional L-type Ca 2ϩ channels are required for the high K ϩ -evoked or FPLevoked RhoA activation. This novel role for VGCC on Ca 2ϩ sensitization in VSM helps explain the KCl-evoked Rho/ROCK activation profusely described in the literature and whose underlying mechanisms were unknown. 6 -10 Our experimental data also indicate that InsP 3 -mediated Ca 2ϩ release is necessary for depolarization-evoked or FPL-evoked RhoA activation, because it was markedly decreased in arterial rings in which the internal Ca 2ϩ stores had been previously depleted. Interestingly, caffeine-induced Ca 2ϩ release did not induce RhoA activation, thus suggesting that SR Ca 2ϩ release per se, bypassing activation of Ca 2ϩ channels and the downstream metabotropic pathway, is not sufficient to induced RhoA activation. Therefore, RhoA/ ROCK activation and VSM sensitization requires both Ca 2ϩ channel activation and CCICR from SR.
In conclusion, the findings reported here suggest that CCICR links Ca 2ϩ channel activation with RhoA/ROCK stimulation. They indicate that depolarization-evoked sustained RhoA activation and myocyte contraction do not depend on the change in the membrane potential itself or the mere release of Ca 2ϩ from the SR, but they require the simultaneous activation of VGCC and the downstream stimulation of a metabotropic pathway, leading to InsP 3 synthesis and Ca 2ϩ release. An explanatory summary of the ionotropic and metabotropic functions of VGCC regulating VSM contraction is given in Figure 8E . Our results could have a wide functional relevance for the pathogenesis of vasospasms mediated by vasoactive agents, such as noradrenalin, endothelin, or ATP, that can activate VGCC. 18, 37, 38 Because sustained VSM depolarization and VGCC activation mediate numerous pathophysiological processes, 39 -42 the data could also help to optimize therapeutic treatment for clinical conditions such as hypertension, angina pectoris, and cardiac arrhythmias, in which Ca 2ϩ channels antagonist are recommended. 43
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